Skipping EXON-v6 from CD44V6-containing isoforms influences chemotherapy response and self-renewal capacity of gastric cancer cells
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC) aggressiveness, and may predict chemotherapy response in vitro. Whether exon-v6 itself is responsible for conferring these properties to CD44v6-containing isoforms remains to be elucidated. CRISPR/C...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/143543 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/143543 |